In a new study, researchers from IBM, Oxford University and Diamond Light Source show that IBM’s AI Model, MoLFormer, can generate antiviral molecules for multiple target virus proteins, including SARS-CoV-2, that can accelerate the drug discovery process and bolster our response to future pandemics.
Click here for original story, The potential of generative AI to accelerate antiviral development and drug discovery
Source: Phys.org